Androgenetic alopecia: An update
JAAD International · 2023-12 · 13 · 150-158
DOI: 10.1016/j.jdin.2023.07.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JAAD International, 2023-12. Verfasst von Sincengile Ntshingila und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hair and Skin Research Laboratory, Division of Dermatology, Department of Medicine, Faculty of Health Sciences and Groote Schuur Hospital, University…. Die Arbeit wurde bisher 163-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation.
Abstract (Originalsprache)
Androgenetic alopecia (AGA) is the most common nonscarring alopecia and is characterised by distinct gradual patterned hair loss. AGA is mediated by genetic predisposition and excessive follicular sensitivity to androgens, mainly in males, leading to the progressive conversion of scalp terminal hair into vellus hair. Although highly prevalent, it is not fatal but may have a severe psychosocial impact, especially on females and younger males. Significant advances have been made in understanding AGA's epidemiology and pathophysiology, but only 2 drugs remain approved by the FDA - finasteride and minoxidil. Prolonged use of these drugs, is a prerequisite for enhanced treatment response. However, this leads to poor medication adherence and adverse effects from extended use eg, the "postfinasteride syndrome" which persists beyond stopping the drug. Hence, there is a need for research on more effective alternative treatments for AGA, with fewer side effects. This paper reviewed recent advances in AGA pathophysiology and its treatment options. The recently characterized structure of type 2, 5-alpha reductase holds significance in comprehending present and prospective treatments of AGA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hair and Skin Research Laboratory, Division of Dermatology, Department of Medicine, Faculty of Health Sciences and Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Förderung
- National Research Foundation
Zitieren
APA
Ntshingila, S., Oputu, O., Arowolo, A. T., & Khumalo, N. P. (2023). Androgenetic alopecia: An update. JAAD International, 13, 150-158. https://doi.org/10.1016/j.jdin.2023.07.005
Vancouver
Ntshingila S, Oputu O, Arowolo AT, Khumalo NP. Androgenetic alopecia: An update. JAAD International. 2023;13:150-158. doi:10.1016/j.jdin.2023.07.005
BibTeX
@article{Ntshingila2023,
author = {Ntshingila, Sincengile and Oputu, Ogheneochuko and Arowolo, Afolake T and Khumalo, Nonhlanhla P},
title = {Androgenetic alopecia: An update},
journal = {JAAD International},
year = {2023},
volume = {13},
pages = {150--158},
doi = {10.1016/j.jdin.2023.07.005}
}
EUVIMED